Asia-Pacific Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Medical Devices Asia Pacific Prostate Cancer Diagnostics Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Asia-Pacific Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Mar 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 193
  • No of Figures: 55
Buy Now Buy Now

Asia-Pacific Prostate Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables and Accessories), Diagnostics Type (Preliminary Screening Tests, Confirmatory Tests), Age Group (Adult, Pediatric and Geriatrics), Type (Prostatic Adenocarcinoma, Small Cell Carcinoma and Others), Stage (Localized Prostate Cancer, Recurrent/Advanced Prostate Cancer and Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)), Sample Type (Blood, Tissue, Urine and Others), End User (Independent Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Retail Sales), Country (Japan, China, Australia, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2028     

Asia-Pacific Prostate Cancer Diagnostics Market Market Analysis and Insights: Asia-Pacific Prostate Cancer Diagnostics Market

The prostate cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 15.1% in the forecast period of 2021 to 2028 and is expected to reach USD 1,703.86 million by 2028. Increasing focus on the disease burden and increasing awareness regarding the disease are the major drivers which are propelling the prostate cancer diagnostics market in the forecast period.

The prostate cancer begins when the cells in the prostate gland started to grow at an abnormal pace and the condition is known to be prostate cancer. The prostate is a gland found only in males. It makes some of the fluid that is part of semen. The prostate cancer diagnostics is a technique of detection of cancer mainly in the early stage to conduct the future treatment approach which can increase the survival rate.

The development of prostate cancer is closely linked with the age, with the increasing geriatric population, there is the significant increase in the incidence for prostate cancer. This will increase the demand for the diagnostics product for the detection of the disease and is expected to act as a driver for the prostate cancer diagnostics market. The PSA testing is one of the primary tests that are used for prostate cancer detection. However, the contradictions between the government and medical services provider for using PSA and related test is expected to restraint the prostate cancer diagnostics market. The market have a huge potential to grow and with the entry of new market players trying to enter market using business expansion via distribution agreements and have invested towards the prostate cancer diagnosis is expected to increase the market size and will act as opportunity for the prostate cancer diagnostics market. The barrier related with conducting the cancer diagnostics test may affect the life of the population and this is one of the most difficult part to overcome with respect to the low income countries, thus this is affecting the diagnostics community and acting as a challenge for the prostate cancer diagnostics market.  

The prostate cancer diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the prostate cancer diagnostics market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Prostate Cancer Diagnostics Market Prostate Cancer Diagnostics Market Scope and Market Size

The prostate cancer diagnostics market is categorized into eight notable segments which are based on the product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the prostate cancer diagnostics market is segmented into instruments, reagents & consumables and accessories. In 2021, reagents & consumables segment is dominating in the prostate cancer diagnostics market as it includes the PSA testing products which is the primary test recommended for preliminary testing.
  • On the basis of diagnostics type, the prostate cancer diagnostics market is segmented into preliminary screening tests and confirmatory tests. In 2021, preliminary screening tests segment is dominating in the prostate cancer diagnostics market as the number of preliminary tests surpass the number of confirmatory tests by significant percentage.  
  • On the basis of age group, the prostate cancer diagnostics market is segmented into adult, pediatric and geriatrics. In 2021, geriatrics segment is dominating in the prostate cancer diagnostics market as around 60% of cases are diagnosed in men over 65 year of age.
  • On the basis of type, the prostate cancer diagnostics market is segmented into prostatic adenocarcinoma, small cell carcinoma and others. In 2021, prostatic adenocarcinoma segment dominates the prostate cancer diagnostics market because more than 95 percent of prostate cancers are adenocarcinomas which develop in the gland cells and line of the prostate gland.
  • On the basis of stage, the prostate cancer diagnostics market is segmented into localized prostate cancer, recurrent/advanced prostate cancer and castration-resistant prostate cancer (metastatic and non-metastatic). In 2021, localized prostate cancer segment dominates the prostate cancer diagnostics market as approximately 80 percent to 85 percent of all prostate cancers are detected in the local or regional stages which represent stages I, II and III.
  • On the basis of sample type, the prostate cancer diagnostics market is segmented into blood, tissue, urine and others. In 2021, blood segment is dominating the prostate cancer diagnostics market as blood is the primary sample for the most common preliminary test that is PSA test and due to easy availability of blood, less complex procedure of blood sample collection doesn’t take much time which is expected to dominate the prostate cancer diagnostics market.  
  • On the basis of end users, the prostate cancer diagnostics market is segmented into independent diagnostic laboratories, hospitals, cancer research institutes, clinics, ambulatory surgical centers and others. In 2021, independent diagnostic laboratories segment is dominating the prostate cancer diagnostics market as the segment is specialized in conducting various prostate cancer diagnostics.
  • On the basis of distribution channel, the prostate cancer diagnostics market is segmented into direct tender and retail sales. In 2021, direct tender segment dominates the prostate cancer diagnostics market as they are the primary source of procurement of reagents, consumables, devices and accessories by healthcare organizations and diagnostic labs.

Asia-Pacific Prostate Cancer Diagnostics Market Country Level Analysis

Asia-Pacific prostate cancer diagnostics market is analysed and market size information is provided by the country, product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel as referenced above.

The countries covered in the Asia-Pacific prostate cancer diagnostics market report are the Japan, China, Australia, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines and rest of Asia-Pacific.

Asia-Pacific is expected to grow with the highest CAGR in the forecasted period as in the Asia-Pacific countries, the demand for prostate cancer diagnostics product is increasing very rapidly with the urbanization. China is expected to dominate in the Asia-Pacific prostate cancer diagnostics market as China has a large population and hence the total number of tests is higher as compared to other countries in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Prostate Cancer Diagnostics Market 

The prostate cancer diagnostics market also provides you with detailed market analysis for every country growth in prostate cancer diagnostics product sales, impact of advancement in the prostate cancer diagnostics and changes in regulatory scenarios with their support for the prostate cancer diagnostics market. The data is available for historic period 2011 to 2019.  

Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis

The prostate cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific prostate cancer diagnostics market.  

The major companies providing Asia-Pacific prostate cancer diagnostics market report are F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., HUMASIS, Hologic Inc., Accuquik Test Kits, Abbott, Siemens Healthcare GmbH, Beckman Coulter, Inc. (a subsidiary of Danaher), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation), bioMérieux SA, Fujirebio, Eurolyser Diagnostica GmbH among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the prostate cancer diagnostics market.

For instance,  

  • In January 2021, Hologic Inc. announced that they have agreed to acquire Biotheranostics, Inc. for USD 230.00 million. This company is the provider of a molecular diagnostic test for metastatic and breast cancer. After the complete acquisition, Hologic Inc. will take a jump start in global oncology detection for cancer patients and will add up to the company’s revenue.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the prostate cancer diagnostics market which also provides the benefit for organisation to improve their offering for prostate cancer diagnostics market.    

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. COMPARATIVE ANALYSIS WITH PARENT MARKET
  6. REGULATORY FRAMEWORK: ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN JAPAN
    2. REGULATORY SCENARIO IN CHINA
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  8. IMPACT OF COVID-19 ON ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. CONCLUSION
  9. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  10. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  11. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  12. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  13. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  14. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  15. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  16. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  17. Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Country
    1. Asia-Pacific
      1. CHINA
      2. JAPAN
      3. India
      4. Australia
      5. SOUTH KOREA
      6. SINGAPORE
      7. THAILAND
      8. MALAYSIA
      9. INDONESIA
      10. Philippines
      11. REST OF Asia-Pacific
  18. ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
    1. company share analysis: Asia-Pacific
  19. SWOT
  20. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. product Portfoli0
      4. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. ACCUQUIK TEST KITS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    6. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    10. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. HUMASIS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

List of Table

TABLE 1 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (USD Million)

TABLE 2 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (UNits)

TABLE 3 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)

TABLE 4 Asia-Pacific preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 5 Asia-Pacific Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 6 Asia-Pacific imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 7 Asia-Pacific Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 8 Asia-Pacific biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 9 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By type, 2019-2028 (USD million)

TABLE 10 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By age group, 2019-2028 (USD Million)

TABLE 11 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By Stage, 2019-2028 (USD Million)

TABLE 12 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By Sample Type, 2019-2028 (USD Million)

TABLE 13 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD Million)

TABLE 14 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By distribution channel, 2019-2028 (USD Million)

TABLE 15 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 16 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 17 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 18 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 19 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 20 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 21 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 22 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 23 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 24 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 25 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 26 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 27 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 28 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 29 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 30 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 31 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 32 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 33 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 34 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 35 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 36 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 37 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 38 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 39 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 40 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 41 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 42 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 43 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 44 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 45 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 46 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 47 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 48 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 49 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 50 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 51 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 52 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 53 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 54 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 55 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 56 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 57 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 58 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 59 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 60 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 61 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 62 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 63 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 64 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 65 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 66 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 67 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 68 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 69 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 70 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 71 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 72 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 73 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 74 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 75 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 76 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 77 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 78 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 79 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 80 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 81 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 82 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 83 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 84 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 85 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 86 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 87 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 88 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 89 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 90 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 91 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 92 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 93 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 94 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 95 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 96 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 97 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 98 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 99 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 100 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 101 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 102 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 103 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 104 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 105 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 106 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 107 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 108 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 109 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 110 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 111 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 112 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 113 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 114 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 115 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 116 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 117 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 118 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 119 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 120 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 121 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 122 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 123 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 124 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 125 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 126 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 127 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 128 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 129 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 130 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 131 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 132 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 133 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 134 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 135 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 136 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 137 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 138 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 139 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 140 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 141 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 142 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 143 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 144 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 145 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 146 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 147 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 148 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 149 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 150 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 151 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 152 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 153 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 154 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 155 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 156 rest of Asia-Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

List of Figure

FIGURE 1 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation

FIGURE 3 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: regional VS country MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID

FIGURE 10 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER, and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE Asia-Pacific prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the Asia-Pacific prostate cancer diagnostics market in 2021 & 2028

FIGURE 14 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 16 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2020

FIGURE 17 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2021-2028 (USD Million)

FIGURE 18 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, CAGR (2021-2028)

FIGURE 19 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE

FIGURE 20 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, 2020

FIGURE 21 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE 2021-2028 (USD Million)

FIGURE 22 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 23 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 24 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2020

FIGURE 25 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2021-2028 (USD Million)

FIGURE 26 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, CAGR (2021-2028)

FIGURE 27 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, LIFELINE CURVE

FIGURE 28 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, 2020

FIGURE 29 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group , 2021-2028 (USD Million)

FIGURE 30 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, CAGR (2021-2028)

FIGURE 31 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, LIFELINE CURVE

FIGURE 32 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2020

FIGURE 33 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2021-2028 (USD Million)

FIGURE 34 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, CAGR (2021-2028)

FIGURE 35 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, LIFELINE CURVE

FIGURE 36 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2020

FIGURE 37 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2021-2028 (USD Million)

FIGURE 38 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, CAGR (2021-2028)

FIGURE 39 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, LIFELINE CURVE

FIGURE 40 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2020

FIGURE 41 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2021-2028 (USD Million)

FIGURE 42 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, CAGR (2021-2028)

FIGURE 43 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, LIFELINE CURVE

FIGURE 44 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2020

FIGURE 45 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2021-2028 (USD Million)

FIGURE 46 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 47 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution, LIFELINE CURVE

FIGURE 48 Asia-Pacific Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 49 Asia-Pacific Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 50 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 51 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 52 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 53 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

At a 15.1% CAGR Asia-Pacific Prostate Cancer Diagnostics Market Forecast by 2028
Asia-Pacific Prostate Cancer Diagnostics Market values $1,703.86 million by 2028.
Asia-Pacific Prostate Cancer Diagnostics Market segmentation is type, stage, sample type, end users, and distribution channel.
Asia-Pacific Prostate Cancer Diagnostics Market report covers Japan, China, Australia, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, and the rest of Asia-Pacific.

Browse Related Pages

Banner